BiotechTube

DIC075V

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ventricular Repolarization

Conditions

Ventricular Repolarization

Trial Timeline

May 1, 2009 → Jul 1, 2009

NCT ID
NCT01812538

About DIC075V

DIC075V is a phase 1 stage product being developed by Pfizer for Ventricular Repolarization. The current trial status is completed. This product is registered under clinical trial identifier NCT01812538. Target conditions include Ventricular Repolarization.

What happened to similar drugs?

2 of 11 similar drugs in Ventricular Repolarization were approved

Approved (2) Terminated (2) Active (7)
✅Beta-blocker treatment groupNovo NordiskApproved
✅Definity® Vial for (Perflutren Lipid Microsphere) Injectable SuspensionLantheus HoldingsApproved
🔄Valsartan + Amlodipine + Hydrochlorothiazide + LosartanNovartisPhase 3
🔄Finerenone (Kerendia, BAY94-8862)BayerPhase 3
🔄Finerenone (Kerendia, BAY94-8862) + PlaceboBayerPhase 3
❌Etripamil + Placebo + Etripamil Test DoseMedpacePhase 3
❌Etripamil NS 70 mgMedpacePhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01812538Phase 1Completed

Competing Products

20 competing products in Ventricular Repolarization

See all competitors
ProductCompanyStageHype Score
ONO-1101Ono PharmaceuticalPhase 2
35
ONO-1101Ono PharmaceuticalPhase 2/3
38
Valsartan + Amlodipine + Hydrochlorothiazide + LosartanNovartisPhase 3
40
ranolazineGilead SciencesPhase 2
35
Eleclazine + Placebo to match eleclazineGilead SciencesPhase 2
35
Beta-blocker treatment groupNovo NordiskApproved
50
Finerenone (BAY94-8862): intervention A + Finerenone (BAY94-8862): intervention BBayerPhase 1
26
Finerenone (Kerendia, BAY94-8862)BayerPhase 3
44
Finerenone (Kerendia, BAY94-8862) + PlaceboBayerPhase 3
44
Inhaled Iloprost + PlaceboBayerPhase 2
24
Etripamil + Placebo + Etripamil Test DoseMedpacePhase 3
29
Etripamil NS 70 mgMedpacePhase 3
29
Etripamil + PlaceboMedpacePhase 2
32
LevosimendanOrion CorporationPre-clinical
23
Definity® Vial for (Perflutren Lipid Microsphere) Injectable SuspensionLantheus HoldingsApproved
40
Flecainide (monotherapy)Brain BiotechPre-clinical
23
MK0954, /Duration of Treatment : 5 Years + Comparator : atenolol /Duration of Treatment : 5 YearsOrganonPhase 3
34
SGT-501Solid BiosciencesPhase 1
30
Etripamil NS 70 mg + PlaceboMilestone PharmaceuticalsPhase 3
30
Etripamil NSMilestone PharmaceuticalsPhase 3
30